Megestrol Acetate as an Appetite Stimulant for Weight Gain
Megestrol acetate is effective for appetite stimulation and weight gain in patients with cancer-related anorexia/cachexia, but carries significant risks including thromboembolic events (1 in 6 patients) and increased mortality (1 in 23 patients). 1, 2
Efficacy and Indications
- FDA-approved for treatment of anorexia, cachexia, or unexplained significant weight loss in patients with AIDS 3
- Commonly used off-label for cancer-related anorexia/cachexia 1, 2
- Effectiveness:
Dosing Recommendations
- Minimum effective dose: 160 mg/day 2, 5
- Optimal dose range: 480-800 mg/day 2
- No evidence that doses above 480 mg/day provide additional efficacy 2
- Dose-response relationship exists for appetite stimulation, but higher doses increase cost and side effects 5
Risk Profile
Megestrol acetate carries significant risks that must be carefully considered:
- Thromboembolic events: 1 in 6 patients (relative risk 1.84) 1, 2
- Mortality risk: 1 in 23 patients will die (relative risk 1.42) 1, 2
- Edema (relative risk 1.36) 2
- No significant improvement in quality of life compared to placebo 6, 7
Comparative Effectiveness
- Superior to dronabinol (cannabis derivatives) for weight gain (75% vs 49% of patients) and appetite improvement (11% vs 3%) in cancer patients 1
- More effective than placebo for weight gain (mean difference 2.25 kg) 6
- Combination therapy approaches may yield better outcomes:
Clinical Algorithm for Use
- First, address reversible causes of anorexia (depression, pain, constipation, nausea/vomiting, oral candidiasis) 1, 2
- Consider megestrol acetate when:
- Patient has cancer or AIDS-related anorexia/cachexia
- Life expectancy is months-to-weeks or weeks-to-days
- Increased appetite is an important aspect of quality of life 1
- Start at 160 mg/day, can increase to 480 mg/day if needed 2, 5
- Monitor weekly for:
- Weight changes
- Thromboembolic complications
- Fluid retention 2
- Discontinue if ineffective after 4 weeks 2
Important Caveats
- Weight gain is primarily fat mass, not lean body mass 4
- Consider combining with exercise program when appropriate to maintain lean body mass 4
- Particularly effective in women with cancer-related cachexia 4
- May be beneficial in pediatric cancer patients with fewer side effects than in adults 8
- Should be used in conjunction with non-pharmacological approaches (small frequent meals, high-calorie foods, pleasant eating environment) 2